PRME vs VLO · rev $4.6M vs P/E 18, rev $76.86B
Prime Medicine, Inc. Common Stock (PRME) versus Valero Energy Corporation (VLO) — a side-by-side from cached financials, not a winner call.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Valero Energy Corporation (VLO) is a oil & gas refining & marketing company listed on NYSE.
Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.
Latest reported VLO revenue for 2026-06-30 was $76.86B. Net income was $4.98B. VLO currently screens at market cap $71.20B and trailing P/E 17.5.
PRME currently screens at market cap $570.8M. VLO currently screens at market cap $71.20B and trailing P/E 17.5.
Not investment advice. Open the PRME and VLO stock pages for the full models.
Not investment advice.